scholarly article | Q13442814 |
P2093 | author name string | Joy Joseph | |
B. Kalyanaraman | |||
Sonya Cunningham | |||
Eugene A. Konorev | |||
Eugene H. Kaji | |||
Shasi V. Kalivendi | |||
Sravan K. Vanamala | |||
P2860 | cites work | Autoxidation of lipids and antioxidation by alpha-tocopherol and ubiquinol in homogeneous solution and in aqueous dispersions of lipids: unrecognized consequences of lipid particle size as exemplified by oxidation of human low density lipoprotein | Q24563896 |
NFAT signaling: choreographing the social lives of cells | Q28216151 | ||
Risk factors for doxorubicin-induced congestive heart failure | Q28328220 | ||
Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation | Q29620223 | ||
Transcriptional regulation by calcium, calcineurin, and NFAT | Q29620410 | ||
Affinity-driven peptide selection of an NFAT inhibitor more selective than cyclosporin A. | Q30778570 | ||
Adriamycin-induced cardiomyocyte and endothelial cell apoptosis: in vitro and in vivo studies. | Q31122965 | ||
Fas-mediated apoptosis in adriamycin-induced cardiomyopathy in rats: In vivo study | Q31419232 | ||
Selective targeting of a redox-active ubiquinone to mitochondria within cells: antioxidant and antiapoptotic properties | Q31621261 | ||
Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy | Q33974366 | ||
Calcineurin signaling and NFAT activation in cardiovascular and skeletal muscle development | Q33975200 | ||
Apoptotic death sensor: an organelle's alter ego? | Q34275400 | ||
Activation of caspases-8 and -10 by FLIP(L). | Q34328223 | ||
Doxorubicin-induced apoptosis: implications in cardiotoxicity | Q34773776 | ||
Doxorubicin-induced cardiac mitochondrionopathy | Q35217039 | ||
Participation of endoplasmic reticulum and mitochondrial calcium handling in apoptosis: more than just neighborhood? | Q35785899 | ||
Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors | Q36253833 | ||
Mitochondrial control of calcium-channel gating: a mechanism for sustained signaling and transcriptional activation in T lymphocytes | Q37253977 | ||
Requirement of nuclear factor of activated T-cells in calcineurin-mediated cardiomyocyte hypertrophy | Q38363027 | ||
Anthracycline antibiotic augmentation of microsomal electron transport and free radical formation | Q39161535 | ||
Effect of antidepressant and neuroleptic drugs on respiratory function of rat heart mitochondria | Q39299720 | ||
Role of iron in adriamycin biochemistry | Q39745692 | ||
Mitochondrial dysfunction is an early indicator of doxorubicin-induced apoptosis | Q40697544 | ||
Doxorubicin-induced apoptosis is associated with increased transcription of endothelial nitric-oxide synthase. Effect of antiapoptotic antioxidants and calcium | Q40777736 | ||
Doxorubicin-induced apoptosis in human T-cell leukemia is mediated by caspase-3 activation in a Fas-independent way. | Q41074621 | ||
Activation of nuclear factor-kappaB during doxorubicin-induced apoptosis in endothelial cells and myocytes is pro-apoptotic: the role of hydrogen peroxide | Q41817128 | ||
Attenuation of drug-stimulated topoisomerase II-DNA cleavable complex formation in wild-type HL-60 cells treated with an intracellular calcium buffer is correlated with decreased cytotoxicity and site-specific hypophosphorylation of topoisomerase II | Q41999727 | ||
Early and delayed clinical cardiotoxicity of doxorubicin | Q42225832 | ||
Reactive oxygen species regulate FLICE inhibitory protein (FLIP) and susceptibility to Fas-mediated apoptosis in cardiac myocytes | Q42435182 | ||
Dose-dependent increase in sensitivity to calcium-induced mitochondrial dysfunction and cardiomyocyte cell injury by doxorubicin | Q42554673 | ||
Expression of the NF-kappa B target gene IEX-1 (p22/PRG1) does not prevent cell death but instead triggers apoptosis in Hela cells | Q43539821 | ||
Interference with calcium-dependent mitochondrial bioenergetics in cardiac myocytes isolated from doxorubicin-treated rats | Q43709644 | ||
Inhibition of the cardiac mitochondrial calcium pump by adriamycin in vitro | Q43992109 | ||
Carvedilol protects against doxorubicin-induced mitochondrial cardiomyopathy | Q44260012 | ||
Tissue inhibitor of metalloproteinases-3 and matrix metalloproteinase-3 regulate neuronal sensitivity to doxorubicin-induced apoptosis | Q44574077 | ||
Doxorubicin induces apoptosis in normal and tumor cells via distinctly different mechanisms. intermediacy of H(2)O(2)- and p53-dependent pathways | Q44822086 | ||
Assay of ubiquinones and ubiquinols as antioxidants | Q46044980 | ||
Autocrine and paracrine apoptosis are mediated by differential regulation of Fas ligand activity in two distinct Jurkat T cell populations | Q48032499 | ||
Endothelial nitric oxide synthase-dependent superoxide generation from adriamycin. | Q52527515 | ||
Adriamycin--an antitumor antibiotic in the treatment of neoplastic diseases | Q68663463 | ||
Pulse radiolysis studies of antitumor quinones: Radical lifetimes, reactivity with oxygen, and one-electron reduction potentials | Q70933229 | ||
One-electron reactions in biochemical systems as studied by pulse radiolysis. 3. Ubiquinone | Q71495014 | ||
Hydrogen Peroxide Stimulates the Ca2+ Release Channel from Skeletal Muscle Sarcoplasmic Reticulum | Q71823683 | ||
Drug-induced apoptosis is associated with enhanced Fas (Apo-1/CD95) ligand expression but occurs independently of Fas (Apo-1/CD95) signaling in human T-acute lymphatic leukemia cells | Q73622800 | ||
Two NFAT transcription factor binding sites participate in the regulation of CD95 (Fas) ligand expression in activated human T cells | Q73935008 | ||
Apoptosis in rat cardiac myocytes induced by Fas ligand: priming for Fas-mediated apoptosis with doxorubicin | Q73975382 | ||
Doxorubicin-induced apoptosis in endothelial cells and cardiomyocytes is ameliorated by nitrone spin traps and ebselen. Role of reactive oxygen and nitrogen species | Q74014516 | ||
Doxorubicin-induced cardiomyopathy | Q77323607 | ||
P433 | issue | Pt 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | doxorubicin | Q18936 |
mitochondrion | Q39572 | ||
reactive oxygen species | Q424361 | ||
lymphocyte | Q715347 | ||
P304 | page(s) | 527–539 | |
P577 | publication date | 2005-07-15 | |
P1433 | published in | Biochemical Journal | Q864221 |
P1476 | title | Doxorubicin activates nuclear factor of activated T-lymphocytes and Fas ligand transcription: role of mitochondrial reactive oxygen species and calcium | |
P478 | volume | 389 |
Q92132585 | AT1 and AT2 receptors modulate renal tubular cell necroptosis in angiotensin II-infused renal injury mice |
Q39030210 | Activation of p38/JNK pathway is responsible for embelin induced apoptosis in lung cancer cells: transitional role of reactive oxygen species |
Q33699632 | Activation of the ubiquitin-proteasome system in doxorubicin cardiomyopathy. |
Q46280877 | Altered Redox Balance in the Development of Chronic Hypoxia-induced Pulmonary Hypertension |
Q46923389 | Angelica sinensis: a novel adjunct to prevent doxorubicin-induced chronic cardiotoxicity |
Q90065293 | Angiotensin II triggers RIPK3-MLKL-mediated necroptosis by activating the Fas/FasL signaling pathway in renal tubular cells |
Q37286660 | Anthocyanin Attenuates Doxorubicin-Induced Cardiomyotoxicity via Estrogen Receptor-α/β and Stabilizes HSF1 to Inhibit the IGF-IIR Apoptotic Pathway |
Q42045584 | Anti-Fas gene therapy prevents doxorubicin-induced acute cardiotoxicity through mechanisms independent of apoptosis |
Q35642302 | Apoptosis in Anthracycline Cardiomyopathy |
Q28388746 | Cardiac-targeted expression of soluble fas attenuates doxorubicin-induced cardiotoxicity in mice |
Q33604134 | Cardiomyocyte death in doxorubicin-induced cardiotoxicity |
Q36609796 | Caspase-dependent and -independent suppression of apoptosis by monoHER in Doxorubicin treated cells. |
Q92879992 | Comprehensive Analysis of Secondary Metabolites in Usnea longissima (Lichenized Ascomycetes, Parmeliaceae) Using UPLC-ESI-QTOF-MS/MS and Pro-Apoptotic Activity of Barbatic Acid |
Q92520508 | Dantrolene Attenuates Cardiotoxicity of Doxorubicin Without Reducing its Antitumor Efficacy in a Breast Cancer Model |
Q37613120 | Decreased Soluble Guanylate Cyclase Contributes to Cardiac Dysfunction Induced by Chronic Doxorubicin Treatment in Mice |
Q33232092 | Defective one- or two-electron reduction of the anticancer anthracycline epirubicin in human heart. Relative importance of vesicular sequestration and impaired efficiency of electron addition. |
Q44184651 | Dietary trans fats enhance doxorubicin-induced cardiotoxicity in mice |
Q54977763 | Downregulation of CUEDC2 prevents doxorubicin‑induced cardiotoxicity in H9c2 cells. |
Q38924111 | Doxorubicin-Mediated Cardiotoxicity: Role of Mitochondrial Connexin 43. |
Q37998724 | Doxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategies |
Q33604236 | Doxorubicin-mediated apoptosis in glioma cells requires NFAT3. |
Q42542336 | Effect of Metformin and Sitagliptin on Doxorubicin-Induced Cardiotoxicity in Rats: Impact of Oxidative Stress, Inflammation, and Apoptosis |
Q35159459 | Endothelin-1 contributes to increased NFATc3 activation by chronic hypoxia in pulmonary arteries |
Q24595633 | Fatty acid amide hydrolase is a key regulator of endocannabinoid-induced myocardial tissue injury |
Q35173610 | Glutathione Peroxidase-1 in Health and Disease: From Molecular Mechanisms to Therapeutic Opportunities |
Q39700191 | Grape seed proanthocyanidins ameliorate Doxorubicin-induced cardiotoxicity. |
Q35753015 | Hsp70 may protect cardiomyocytes from stress-induced injury by inhibiting Fas-mediated apoptosis |
Q46773084 | Hyperbaric oxygen therapy does not potentiate doxorubicin-induced cardiotoxicity in rats. |
Q35240656 | Immediate early response gene X-1, a potential prognostic biomarker in cancers |
Q37375571 | Increased manganese superoxide dismutase expression or treatment with manganese porphyrin potentiates dexamethasone-induced apoptosis in lymphoma cells |
Q38779463 | Increasing role of the cancer chemotherapeutic doxorubicin in cellular metabolism |
Q39879881 | Inhibition of constitutive activity of nuclear transcription factor kappaB sensitizes doxorubicin-resistant cells to apoptosis |
Q26771260 | Innovative Target Therapies Are Able to Block the Inflammation Associated with Dysfunction of the Cholesterol Biosynthesis Pathway |
Q37519229 | Intermittent hypoxia-induced increases in reactive oxygen species activate NFATc3 increasing endothelin-1 vasoconstrictor reactivity |
Q24310510 | Involvement of an aldo-keto reductase (AKR1C3) in redox cycling of 9,10-phenanthrenequinone leading to apoptosis in human endothelial cells |
Q36667033 | Liensinine- and Neferine-Induced Cardiotoxicity in Primary Neonatal Rat Cardiomyocytes and Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes. |
Q36073942 | Loss of Selenium-Binding Protein 1 Decreases Sensitivity to Clastogens and Intracellular Selenium Content in HeLa Cells |
Q38473474 | Mechanisms and management of doxorubicin cardiotoxicity |
Q30500834 | Mechanisms of noise-induced hearing loss indicate multiple methods of prevention |
Q58611546 | Mitochondria as a therapeutic target for common pathologies |
Q39400621 | Mitochondria-Targeted Triphenylphosphonium-Based Compounds: Syntheses, Mechanisms of Action, and Therapeutic and Diagnostic Applications. |
Q39426373 | Mitochondria-targeted antioxidants protect pancreatic β-cells against oxidative stress and improve insulin secretion in glucotoxicity and glucolipotoxicity |
Q34074451 | Mitochondrial complex II prevents hypoxic but not calcium- and proapoptotic Bcl-2 protein-induced mitochondrial membrane potential loss |
Q95797465 | Morphine inhibits doxorubicin-induced reactive oxygen species generation and nuclear factor kappaB transcriptional activation in neuroblastoma SH-SY5Y cells |
Q36837739 | NFAT is required for spontaneous pulmonary hypertension in superoxide dismutase 1 knockout mice |
Q36552392 | New insights into doxorubicin-induced cardiotoxicity: the critical role of cellular energetics. |
Q53755850 | Pentoxifylline abrogates cardiotoxicity induced by the administration of a single high dose or multiple low doses of doxorubicin in rats. |
Q30341525 | Phylogenetic origin of LI-cadherin revealed by protein and gene structure analysis. |
Q37189802 | Placental mesenchymal and cord blood stem cell therapy for dilated cardiomyopathy |
Q36120762 | Platinum nanoparticles reduce ovariectomy-induced bone loss by decreasing osteoclastogenesis |
Q45853133 | Preventive effects of ellagic acid against doxorubicin-induced cardio-toxicity in mice |
Q38654368 | Prophylactic supplementation of resveratrol is more effective than its therapeutic use against doxorubicin induced cardiotoxicity. |
Q41680030 | Protective effect of p-coumaric acid against doxorubicin induced toxicity in H9c2 cardiomyoblast cell lines. |
Q46941129 | Ranolazine protects from doxorubicin-induced oxidative stress and cardiac dysfunction. |
Q33556178 | Regulation of PSMB5 protein and β subunits of mammalian proteasome by constitutively activated signal transducer and activator of transcription 3 (STAT3): potential role in bortezomib-mediated anticancer therapy |
Q30804911 | Regulation of gene expression by NFAT transcription factors in hibernating ground squirrels is dependent on the cellular environment |
Q28391569 | Regulation of signal transduction by reactive oxygen species in the cardiovascular system |
Q40070279 | Role of mitochondrial reactive oxygen species in osteoclast differentiation |
Q61809301 | Rosmarinic acid alleviates cardiomyocyte apoptosis via cardiac fibroblast in doxorubicin-induced cardiotoxicity |
Q37072696 | TRPC6 channel activation promotes neonatal glomerular mesangial cell apoptosis via calcineurin/NFAT and FasL/Fas signaling pathways. |
Q34251106 | The antioxidant transcription factor Nrf2 negatively regulates autophagy and growth arrest induced by the anticancer redox agent mitoquinone |
Q39952894 | The forkhead transcription factor FOXO4 sensitizes cancer cells to doxorubicin-mediated cytotoxicity |
Q40150613 | sHA 14-1, a stable and ROS-free antagonist against anti-apoptotic Bcl-2 proteins, bypasses drug resistances and synergizes cancer therapies in human leukemia cell |
Search more.